Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status

Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuc...

Full description

Saved in:
Bibliographic Details
Published in:Orbit (Amsterdam) 2012-12, Vol.31 (6), p.386-389
Main Authors: Gupta, Aanchal, Prabhakaran, Venkatesh C., Dodd, Tom, Davis, Garry, Selva, Dinesh
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal, Murine-Derived - metabolism
Biomarkers, Tumor - metabolism
Cavernous haemangioma
Cell Differentiation
Cell Proliferation
Differentiation
Hemangioma, Cavernous - metabolism
Humans
Immunohistochemistry
Orbital Neoplasms - metabolism
Platelet Endothelial Cell Adhesion Molecule-1 - metabolism
Proliferating Cell Nuclear Antigen - metabolism
Proliferation
Receptors, Estrogen - metabolism
Receptors, Progesterone - metabolism
Vascular Endothelial Growth Factor A - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuclear antigen (PCNA), Bcl-2, estrogen and progesterone receptors (ER & PR), CD31, D2-40, and VEGF were investigated in 11 specimens. Results: Immunohistochemical staining revealed positivity for PCNA in ten of the 11 cases (91%). Bcl-2 was positive in 8 cases (73%). VEGF and PR were each weakly positive in 3 cases. All cases were negative for Mib-1, ER and D2-40. The staining was localized around the endothelium. Conclusion: This is the first study to characterise in detail the immunohistochemical features of orbital CHs. The proliferative markers PCNA and Mib-1 show discordant expression in these lesions and the expression of PCNA and Bcl-2 in the absence of Mib-1 is indicative of low proliferative potential. Small subsets of these tumors express PR and VEGF, which may partly explain the proliferative capacity of some orbital CHs.
ISSN:0167-6830
1744-5108
DOI:10.3109/01676830.2012.711887